Masimo

Irvine, CA, United States All United States companies → — Founded 1989

Healthcare Conglomerate Medical Device / Hardware Wearables / RPM

Cardiology Hospital Medicine Internal Medicine

Patient Engagement & Education

Acquired

Claim this company

Products

Masimo SafetyNet

Masimo Corporation

Patient Engagement & Education

Masimo SafetyNet is a cloud-based telehealth platform for remote patient monitoring, offering customizable CarePrograms, a patient mobile app, and a clinician portal to extend care from the hospital to home.

Contact for pricing

See all 1 product →

About Masimo

Masimo is a global medical technology company renowned for its innovative non-invasive patient monitoring solutions and hospital automation platforms. For physicians, Masimo’s core offerings center on its proprietary Signal Extraction Technology (SET®) pulse oximetry, which provides accurate measurements even during patient motion and low perfusion, a critical advancement in vital sign monitoring. Beyond pulse oximetry, Masimo’s portfolio includes advanced Pulse CO-Oximetry for non-invasive measurement of various blood constituents like total hemoglobin (SpHb®) and carboxyhemoglobin (SpCO®), as well as brain function monitoring (SedLine®), regional oximetry (O3®), and capnography.

Increasingly, Masimo leverages artificial intelligence (AI) to enhance clinical decision-making and streamline workflows. Its Hospital Automation™ platform, driven by AI, integrates data from Masimo and third-party devices into electronic medical records (EMRs), aiming to provide a more complete patient picture and proactively identify potential deterioration. Solutions like Visual Clinical Activity Monitoring (VCAM™) utilize AI for hand hygiene compliance, demonstrating Masimo’s commitment to improving patient safety and operational efficiency through intelligent systems. The company also extends its monitoring capabilities to remote and home care settings with platforms like Masimo SafetyNet®, which can integrate with wearables like the Masimo W1™ medical watch.

Masimo’s mission is to improve patient outcomes and reduce the cost of care by expanding non-invasive monitoring to new applications and locations, from acute care to home environments. The company emphasizes continuous innovation, clinical evidence, and patient safety, aiming to transform patient care through advanced monitoring and data-driven insights.

Focus Areas

non-invasive patient monitoring pulse oximetry signal processing AI-enabled monitoring remote patient monitoring hospital automation connectivity solutions hemodynamic monitoring brain function monitoring regional oximetry capnography

Business Intelligence

Technology

Signal Extraction Technology (SET), smartSET pulse oximetry sensor platform, Masimo Hospital Automation™ platform, Root Patient Monitoring and Connectivity Platform, Iris® platform, Masimo SafetyNet (cloud-based telehealth platform)

What Physicians Need to Know

Noninvasive Patient Monitoring

Masimo specializes in advanced noninvasive monitoring, including breakthrough Signal Extraction Technology (SETu00ae) pulse oximetry for accurate SpO2 readings even during motion and low perfusion, and rainbowu00ae Pulse CO-Oximetry for continuous, noninvasive measurement of multiple blood constituents like total hemoglobin (SpHbu00ae), carboxyhemoglobin (SpCOu00ae), and methemoglobin (SpMetu00ae). They also offer brain function monitoring (SedLineu00ae), regional oximetry (O3u00ae), capnography (EtCO2), and acoustic respiration rate (RRau00ae).

Medical Devices & Sensors

Key devices include the Rootu00ae Patient Monitoring and Connectivity Platform, which centralizes multiple noninvasive technologies and serves as a connectivity hub. Other devices like Rad-97u2122, Rad-67u2122, and MightySatu2122 Rx provide versatile monitoring solutions for various care settings, including portable and spot-check capabilities. Sensors are designed for clinical-grade accuracy across acute care, alternate sites, and consumer-adjacent monitoring.

Hospital Automation & Connectivity

Masimo Hospital Automationu2122 integrates patient monitoring with sophisticated connectivity and interoperability solutions, such as Iris Gatewayu2122 and Patient SafetyNetu2122, to provide seamless access to accurate patient data. This platform aims to simplify care delivery, maximize resources, decrease variability, and improve patient outcomes by automating data collection and transfer to EMRs.

Remote Patient Monitoring (RPM)

Masimo SafetyNetu00ae is a scalable, cloud-based patient management and telehealth solution that combines wearable sensors (e.g., Radius PPGu2122, Radius Tu00bau00ae, Masimo W1u2122 medical watch) with a mobile app and web-based clinician dashboard for continuous remote monitoring. This enables hospital-grade monitoring at home, aiming to reduce hospitalizations, deaths, and costs.

AI-based Video Analysis & Predictive Analytics

Masimo's Hospital Automation platform includes novel AI capabilities that support intelligent patient prioritization and help clinicians identify changes in patients' conditions more efficiently. They are also involved in joint development initiatives on predictive analytics and AI-based algorithms, particularly for improving cardiac care, through collaborations like the one with Cleveland Clinic.

Consumer Health Products & Wearables

The Masimo W1u2122 medical watch is a key offering in consumer health, designed to bring highly accurate patient monitoring from the hospital to the home, with clinicians noting its potential advantages over other health-tracking watches.

Physician Tip

For physicians, Masimo stands out due to its clinically validated accuracy, particularly with SETu00ae pulse oximetry, which performs reliably even during patient motion, low perfusion, and across diverse skin tones, significantly reducing false alarms. The rainbowu00ae technology offers a comprehensive, noninvasive view of patient status by monitoring parameters like total hemoglobin, reducing the need for invasive blood draws. The Rootu00ae platform centralizes various monitoring modalities, simplifying complex patient data into an intuitive display, and its expandability allows for tailored monitoring solutions. Masimo's automation and connectivity solutions, including Patient SafetyNetu2122 and Iris Gatewayu2122, streamline workflows by automating charting and providing remote clinician notifications, freeing up valuable time for direct patient care and reducing transcription errors. Furthermore, solutions like SedLineu00ae brain function monitoring aid in precise anesthesia dosing, potentially leading to faster emergence and reduced post-anesthesia complications. The ability to extend hospital-grade monitoring to the home via Masimo SafetyNetu2122 supports continuity of care, early intervention, and can contribute to reduced hospitalizations and improved patient outcomes.

Masimo's Rootu00ae platform and Iris Gatewayu2122 are designed for robust integration, serving as connectivity hubs that can centralize data from both Masimo and third-party devices. This facilitates automated electronic charting into Electronic Medical Records (EMRs) and Patient Data Management Systems (PDMS), ensuring a continuous flow of patient information across the continuum of care and breaking down data silos. Masimo also collaborates with technology leaders and offers OEM solutions, allowing their monitoring technologies to be integrated into devices from numerous third-party manufacturers, including Philips, GE Healthcare, and Mindray.

Products by Masimo

1 product in the directory

Masimo SafetyNet

Masimo Corporation

Patient Engagement & Education

Contact for pricing

What the Web Says

Masimo generally receives positive to mixed reviews for its medical devices, particularly pulse oximetry, which is often praised for accuracy and reliability. However, the company's employer reviews on platforms like Glassdoor indicate a more mixed sentiment, with concerns about management, work-life balance, and company culture, despite appreciation for compensation and benefits in some areas.

Overall: Mixed

Strengths

Highly accurate and reliable pulse oximetry technology (SETu00ae)
Products are considered innovative and high-quality by many healthcare professionals
Good compensation and benefits for some roles/departments
Strong product performance in critical care settings
Positive impact on patient care due to advanced monitoring capabilities
Opportunities for professional growth for some employees

Limitations

Challenging work-life balance and long hours reported by employees
Issues with management and internal communication cited in employer reviews
Company culture can be demanding and stressful
Customer service and technical support can be inconsistent or slow for some users
High cost of devices and consumables can be a barrier for some healthcare providers
Recent controversies and legal disputes have raised concerns

Based on reviews from: G2, Glassdoor, Capterra, Reddit, Healthcare IT News (various articles/reviews), KLAS Research (indirect mentions/comparisons)

Last updated: 2026-07-19

Videos

News, demos, and interviews about Masimo.

Loading videos...

Videos load interactively. If none appear, search YouTube for Masimo →

View all on YouTube

Press & Coverage

Business Wire

Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner

Masimo, a Danaher company, announced FDA 510(k) clearance for an AI-enabled opioid-induced respiratory depression detection capability integrated into its Radius VSM wearable continuous patient monitor. This feature uses advanced pattern recognition to identify early signs of respiratory compromise in patients receiving opioid therapy.

2026-06

PRNewswire

Masimo Receives FDA 510(k) Clearance for Root® with LiDCO® and the Masimo LiDCO Sensor to Provide Continuous Oxygen Delivery (DO₂)

Masimo announced FDA 510(k) clearance for its Root® with LiDCO® hemodynamic monitoring solution, including the Masimo LiDCO sensor. This solution provides continuous monitoring and trending of oxygen delivery (DO₂), unifying cardiac output, hemoglobin, and oxygen saturation.

2026-08

Healthcare Dive

Danaher to buy Masimo for $9.9B to boost diagnostics portfolio

Danaher Corporation agreed to acquire Masimo for $9.9 billion to strengthen its diagnostics portfolio. Masimo will operate as a standalone business unit within Danaher's Diagnostics segment, focusing on acute care settings.

2026-02

MassDevice

Masimo gets FDA nod for AI-enabled OIRD detection tech

Masimo received FDA clearance for its AI-enabled opioid-induced respiratory depression (OIRD) detection platform for the Radius VSM wearable continuous patient monitor. The technology uses advanced pattern recognition to alert clinicians to changing conditions.

2026-06

Medical Device Network

Masimo Receives FDA Clearance for Atrial Fibrillation (AFib) Detection on Radius VSM®

Masimo received FDA clearance for atrial fibrillation (AFib) detection via its Radius VSM. This technology uses pattern recognition and AI-based signal analysis of pulse waveform data to support earlier evaluation and intervention for irregular heart rhythms.

2026-10

Masimo

Masimo Announces Reinstatement of Import Ban on Infringing Apple Watches

Masimo announced the Federal Circuit's ruling to lift the temporary stay on the import ban of certain Apple Watch models, following a patent infringement case related to light-based pulse oximetry.

2026-01

Business Wire

Masimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable Growth

Masimo outlined its long-term strategy and financial targets through 2028, focusing on expanding its leadership in patient monitoring, multi-year pipeline development, and delivering revenue growth and margin expansion.

2025-12

Masimo

Masimo SET® Pulse Oximetry Performed Accurately on Hospitalized Newborns of All Skin Tones in Largest-Ever Prospective Real-world Study

A study demonstrated the accuracy of Masimo SET® pulse oximetry among critically ill neonates, showing less than 1% overall statistical bias and accurate performance across all skin tones.

2026-04

Frequently Asked Questions

What are Masimo's core noninvasive monitoring technologies and how do they differentiate from competitors?

Masimo's core noninvasive monitoring technologies, particularly Signal Extraction Technology (SET) pulse oximetry, are renowned for providing accurate readings even during patient motion and low perfusion. This capability significantly differentiates them from conventional pulse oximetry and is widely adopted in many leading hospitals globally.

What advanced monitoring parameters does Masimo offer beyond pulse oximetry, and what are their clinical applications?

Beyond pulse oximetry, Masimo offers advanced noninvasive monitoring solutions such as rainbow SET technology for continuous total hemoglobin (SpHb), carboxyhemoglobin (SpCO), and methemoglobin (SpMet). They also provide brain function monitoring (SedLine), regional oximetry (O3), capnography (NomoLine), acoustic respiration rate, and advanced hemodynamic monitoring through the LiDCO system, which are crucial for perioperative care and critical care settings.

How do Masimo's connectivity and hospital automation solutions integrate with existing hospital IT infrastructure and EMRs?

Masimo's Hospital Automation platform, including iSirona and Iris Gateway, is designed to seamlessly integrate various medical devices and automatically transfer patient data into Electronic Medical Records (EMRs). This system aims to enhance productivity, minimize transcription errors, and streamline data flow across the entire care continuum.

What is Masimo's strategy for remote patient monitoring and consumer health, and how do these offerings integrate with their professional medical devices?

Masimo's strategy for remote patient monitoring (RPM) and consumer health focuses on extending hospital-grade monitoring to home environments using platforms like Masimo SafetyNet. While they are developing consumer wearables such as the Masimo W1 watch for continuous health tracking, the company is strategically divesting its consumer audio business to sharpen its focus on medical innovations.

How does Masimo ensure regulatory compliance and data security for its medical devices and cloud-based solutions?

Masimo adheres to stringent ethical and legal standards, with policies aligned with the AdvaMed Code of Ethics for interactions with healthcare professionals. For data security, particularly with cloud-based solutions like Masimo SafetyNet, they implement end-to-end security measures, securely host personal data, and obtain explicit patient consent for data processing. Although a cybersecurity breach affected manufacturing in 2025, Masimo initiated investigations and stated that its cloud-based systems remained unaffected.

Can you elaborate on Masimo's pricing structure, technical support, and partnership models for healthcare systems?

Masimo's healthcare revenue model largely relies on recurring consumables and service contracts, contributing to gross margins exceeding 60% in its medical segment. The company provides dedicated technical and clinical support, and actively engages in strategic partnerships with healthcare systems, such as Temple Health and UCHealth, to advance telehealth and automation initiatives. Additionally, Masimo collaborates with other medical device manufacturers like Philips to integrate its advanced monitoring technologies into their platforms.

What is Masimo's long-term vision and commitment to innovation in patient monitoring and healthcare technology?

Masimo's long-term vision is to globally advance patient monitoring through continuous innovation, aiming to improve patient outcomes and reduce healthcare costs. The company is strategically refocusing on its core healthcare technology, including a planned divestiture of its consumer audio business, to emphasize high-margin medical consumables and clinical surveillance. They maintain a strong commitment to R&D and strategic growth in noninvasive monitoring solutions.